These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 16924498

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Paclitaxel poliglumex (PPX, CT-2103): macromolecular medicine for advanced non-small-cell lung cancer.
    Bonomi P.
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):415-22. PubMed ID: 17428162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.
    Li C, Yu DF, Newman RA, Cabral F, Stephens LC, Hunter N, Milas L, Wallace S.
    Cancer Res; 1998 Jun 01; 58(11):2404-9. PubMed ID: 9622081
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo metabolism of epothilone B in tumor-bearing nude mice: identification of three new epothilone B metabolites by capillary high-pressure liquid chromatography/mass spectrometry/tandem mass spectrometry.
    Blum W, Aichholz R, Ramstein P, Kühnöl J, Brüggen J, O'Reilly T, Flörsheimer A.
    Rapid Commun Mass Spectrom; 2001 Jun 01; 15(1):41-9. PubMed ID: 11135423
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane.
    Singer JW, Shaffer S, Baker B, Bernareggi A, Stromatt S, Nienstedt D, Besman M.
    Anticancer Drugs; 2005 Mar 01; 16(3):243-54. PubMed ID: 15711176
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.
    Cancer Chemother Pharmacol; 2008 Nov 01; 62(6):1045-54. PubMed ID: 18301895
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel poliglumex for ovarian cancer.
    Galic VL, Wright JD, Lewin SN, Herzog TJ.
    Expert Opin Investig Drugs; 2011 Jun 01; 20(6):813-21. PubMed ID: 21470062
    [Abstract] [Full Text] [Related]

  • 17. Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant.
    Shikanov A, Shikanov S, Vaisman B, Golenser J, Domb AJ.
    Int J Pharm; 2008 Jun 24; 358(1-2):114-20. PubMed ID: 18406086
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel poliglumex. Cell Therapeutics/Chugai Pharmaceutical.
    Man M, Rugo H.
    IDrugs; 2005 Sep 24; 8(9):739-54. PubMed ID: 16118697
    [Abstract] [Full Text] [Related]

  • 19. Preclinical efficacy spectrum and pharmacokinetics of ixabepilone.
    Lee FY, Smykla R, Johnston K, Menard K, McGlinchey K, Peterson RW, Wiebesiek A, Vite G, Fairchild CR, Kramer R.
    Cancer Chemother Pharmacol; 2009 Jan 24; 63(2):201-12. PubMed ID: 18350296
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.